McKesson — Aug 5, 2026 release

First Quarter Highlights: • Consolidated revenues of $105.4 billion increased 8%. • Earnings per diluted share of $5.15 decreased $1.10. • Adjusted Earnings per Diluted Share of $9.93 increased 20%. • McKesson's Board of Directors approved a 15% increase to the quarterly dividend, to $0.94 per share. This marks the tenth consecutive year of dividend increases. • McKesson returned $2.6 billion to shareholders, including $2.25 billion through the May 2026 accelerated share repurchase program. Fiscal 2027 Full Year Outlook: • Raised Adjusted Earnings per Diluted Share guidance range to $44.20 to $45.00, from the previous range of $43.80 to $44.60. • Fiscal 2027 Adjusted Earnings per Diluted Share guidance range indicates 13% to 15% growth compared to the prior year. • The Company does not forecast GAAP earnings per diluted share 1 . “McKesson delivered a strong start to fiscal 2027, underscored by momentum across the enterprise and disciplined execution against our strategic priorities,” said Brian Tyler, chair and chief executive officer. “Our first quarter performance exceeded our expectations, highlighted by 20% growth in Adjusted Earnings per Diluted Share. It demonstrates the strength of our core distribution businesses, continued growth in oncology and multispecialty, and solid execution across our biopharma services platform. These results are a testament to the dedication of Team McKesson, whose commitment to excellence continues to drive our success and impact across he